Alison Joyce
Overview
Explore the profile of Alison Joyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bivi N, Graham D, Joglekar L, McGuire K, Stoop J, Zoghbi J, et al.
Bioanalysis
. 2025 Jan;
17(4):211-248.
PMID: 39862107
The 18th Workshop on Recent Issues in Bioanalysis (18th WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple...
2.
Miller G, Caiazzo T, Joyce A
J Immunol Methods
. 2024 Aug;
533:113742.
PMID: 39153729
Stability of conjugated critical reagents supporting ligand binding assays to enable biotherapeutic drug development is a universal concern. Formulation buffer employed for long-term cold storage may be key to mitigate...
3.
Sumner G, Keller S, Huleatt J, Staack R, Wagner L, Azadeh M, et al.
Bioanalysis
. 2023 Aug;
15(15):861-903.
PMID: 37584363
The 16 Workshop on Recent Issues in Bioanalysis (16 WRIB) took place in Atlanta, GA, USA on September 26-30, 2022. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
4.
Pan L, Mora J, Walravens K, Wagner L, Hopper S, Loo L, et al.
Bioanalysis
. 2023 Aug;
15(14):773-814.
PMID: 37526071
The 2022 16th Workshop on Recent Issues in Bioanalysis (WRIB) took place in Atlanta, GA, USA on September 26-30, 2022. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory...
5.
Joyce A, Shea C, You Z, Gorovits B, Lepsy C
AAPS J
. 2022 Nov;
24(6):114.
PMID: 36324032
Characterization of clinical anti-drug antibody (ADA) responses to biotherapeutics can be important to understanding the consequences of immunogenicity. ADA are expected to be polyclonal, with composition and affinities that evolve...
6.
Wang Y, Crowell S, Joyce A, Dyleski L, Messing D, Cargill J, et al.
Pharm Res
. 2021 May;
38(5):819-830.
PMID: 33982224
Purpose: The purpose of this study was to evaluate the suitability of whole blood microsampling procedures in non-human primate (NHP) to support toxicokinetic assessments of biotherapeutics in non-human primates. Method:...
7.
Spitz S, Zhang Y, Fischer S, McGuire K, Sommer U, Amaravadi L, et al.
Bioanalysis
. 2021 Jan;
13(5):295-361.
PMID: 33511867
The 14 edition of the Workshop on Recent Issues in Bioanalysis (14 WRIB) was held virtually on June 15-29, 2020 with an attendance of over 1000 representatives from pharmaceutical/biopharmaceutical companies,...
8.
Breen D, Kim H, Bennett D, Calle R, Collins S, Esquejo R, et al.
Cell Metab
. 2020 Nov;
32(6):938-950.e6.
PMID: 33207247
Platinum-based cancer therapy is restricted by dose-limiting side effects and is associated with elevation of growth differentiation factor 15 (GDF-15). But whether this elevation contributes to such side effects has...
9.
Padmanabhan S, Lanz T, Gorman D, Wolfe M, Joyce A, Cabrera C, et al.
J Parkinsons Dis
. 2020 Feb;
10(2):623-629.
PMID: 32007961
The phosphorylated form of LRRK2, pS935 LRRK2, has been proposed as a target modulation biomarker for LRRK2 inhibitors. The primary aim of the study was to characterize and qualify this...
10.
Piccoli S, Mehta D, Vitaliti A, Allinson J, Amur S, Eck S, et al.
Bioanalysis
. 2019 Dec;
11(24):2207-2244.
PMID: 31820675
The 2019 13 Workshop on Recent Issues in Bioanalysis (WRIB) took place in New Orleans, LA, USA on April 1-5, 2019 with an attendance of over 1000 representatives from pharmaceutical/biopharmaceutical...